Plasma 25-hydroxyvitamin D levels and survival in stage III colon cancer: Findings from CALGB/SWOG 80702 (Alliance).
Qiao-Li WangChao MaChen YuanQian ShiBrian M WolpinYin ZhangCharles S FuchsJeffrey MeyerTyler ZemlaEn ChengPriya U KumthekarKatherine A GuthrieFelix CouturePhilip KueblerPankaj KumarBenjamin TanSmitha KrishnamurthiRichard M GoldbergAlan P VenookCharles David BlankeAnthony Frank ShieldsEileen M O'ReillyJeffrey A MeyerhardtKimmie NgPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Non-deficient vitamin D is associated with improved outcomes in patients with stage III colon cancer, largely independent of circulation inflammations. A randomized trial is warranted to elucidate if adjuvant vitamin D supplementation improves patient outcomes.